Literature DB >> 11933703

[Arterial hypertension in Mexico: results of the National Health Survey 2000].

Oscar Velázquez Monroy1, Martín Rosas Peralta, Agustín Lara Esqueda, Gustavo Pastelín Hernández, Fause Attie, Roberto Tapia Conyer.   

Abstract

AIMS: Hypertension remains as a major cause of cardiovascular morbidity in México. The Health National Survey 2000 of México was performed to analyze the current status of the prevalence of some risk factors such as diabetes, hypertension (HTA), obesity, smoking, and proteinuria.
METHODS: A National Survey was carried out in México where 45,300 individuals between 20 to 69-y.o. were screened. The estimated sample size was calculated considering the total number of persons into the mentioned age; a minimal prevalence of 6% of the included risk factors, at a significance level of 0.05; a maximum relative error of 0.145, and a rate of response of at least 70%. Diagnosis of HTA was accepted in: previous medical diagnosis with prescription of antihypertensive drugs, or high blood pressure (> or = 140/90 mmHg) detected during the interview. Data were adjusted for the national distribution of age-groups and gender (established in 2000, INEGI).
RESULTS: 38,377 (98.8%) individuals were correctly screened for blood pressure. The prevalence of hypertension in México was 30.05% (34.2% in men and 26.3% in women). The prevalence was directly related with age and gender. The percentage of mexicans with HTA after 50-y.o. is > 50%. The prevalence was greater in women after 50-y.o. Among persons with hypertension, treatment was detected in 46% and approximately 20% of them were controlled (< 140/90 mmHg). The percentage of mexicans with HTA who were unaware that they have high blood pressure was 61%. The total percentage of HTA controlled was 14.6%. The North states had the greater prevalence (approximately 34%) of HTA while South states had the lower prevalence (27%). The odds ratio (age/sex-adjusted) for HTA were: for diabetes 1.54(CI95%, 1.44-1.63); for obesity 2.3 (CI 95%, 2.22-2.43); for smoking 1.26 (CI 95%, 1.21-1.32). For proteinuria subjects, 40% had HTA.
CONCLUSIONS: Around 15 millions of mexicans between 20 to 69-y.o. had hypertension, 60% of them are unaware. The prevalence of hypertension in México (30.05%) has increased. Among persons with hypertension -15% are controlled. The North of México has the higher prevalence of hypertension. Diabetes, smoking, and obesity increase the risk of hypertension. The 2000 National Survey of Health shows the epidemiological trend in several important chronic diseases in México and declare an urgent need of new strategies for detection, control and treatment of hypertension.

Entities:  

Mesh:

Year:  2002        PMID: 11933703

Source DB:  PubMed          Journal:  Arch Cardiol Mex        ISSN: 1665-1731


  9 in total

1.  Hypertension as a risk factor for developing depressive symptoms among community-dwelling elders.

Authors:  Luis García-Fabela; Efrén Melano-Carranza; Sara Aguilar-Navarro; Juan Miguel Antonio García-Lara; Luis Miguel Gutiérrez-Robledo; José Alberto Avila-Funes
Journal:  Rev Invest Clin       Date:  2009 Jul-Aug       Impact factor: 1.451

Review 2.  AAV Delivery of Endothelin-1 shRNA Attenuates Cold-Induced Hypertension.

Authors:  Peter Gin-Fu Chen; Zhongjie Sun
Journal:  Hum Gene Ther       Date:  2016-10-11       Impact factor: 5.695

3.  The prevalence of hypertension in older Mexicans and Mexican Americans.

Authors:  Jennifer J Salinas; Karl A Eschbach; Kyriakos S Markides
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

4.  AAV-based RNAi silencing of NADPH oxidase gp91(phox) attenuates cold-induced cardiovascular dysfunction.

Authors:  Xiuqing Wang; Lucille Skelley; Bo Wang; Ayesha Mejia; Val Sapozhnikov; Zhongjie Sun
Journal:  Hum Gene Ther       Date:  2012-08-13       Impact factor: 5.695

5.  Efficacy of a fixed-dose combination of trandolapril-verapamil in patients with stage 2 hypertension inadequately controlled by monotherapy.

Authors:  Alberto Francisco Rubio-Guerra; Adalberto Arceo-Navarro; José Juan Lozano-Nuevo; Germán Vargas-Ayala; Leticia Rodríguez-López; Luz María Ramos-Brizuela
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Establishment of Health Clinics as Mass Screening and Referral Systems for Chronic Non-communicable Diseases in Primary Health Care.

Authors:  Kamal Heidari; Sayyed Ali Sajjadi; Rezvaneh Hadian; Somayeh Hadi; Ramesh Hosseinkhani; Soudabeh Amini; Zahra Kiani; Ali Ajami; Reza Fadaei; Anahita Shahriari; Kasra Keramatian
Journal:  Int J Prev Med       Date:  2012-03

7.  Pausa para tu Salud: reduction of weight and waistlines by integrating exercise breaks into workplace organizational routine.

Authors:  Agustin Lara; Antronette K Yancey; Roberto Tapia-Conye; Yvonne Flores; Pablo Kuri-Morales; Ritesh Mistry; Elena Subirats; William J McCarthy
Journal:  Prev Chronic Dis       Date:  2007-12-15       Impact factor: 2.830

Review 8.  Hibiscus sabdariffa L., roselle calyx, from ethnobotany to pharmacology.

Authors:  Octavio Carvajal-Zarrabal; Dulce María Barradas-Dermitz; Zaida Orta-Flores; Patricia Margaret Hayward-Jones; Cirilo Nolasco-Hipólito; M Guadalupe Aguilar-Uscanga; Anilú Miranda-Medina; Kopli Bin Bujang
Journal:  J Exp Pharmacol       Date:  2012-02-28

9.  Prevalence of Hypertension in Adult Population of A Village of Nepal.

Authors:  Smriti Khanal; Krishna Rana; Milan Chandra Khanal; Astha Prasai; Anjila Pradhan; Manisha Shahi
Journal:  JNMA J Nepal Med Assoc       Date:  2019 Jul-Aug       Impact factor: 0.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.